Literature DB >> 17703342

Plasma exchange therapy for steroid-refractory superimposed relapses in secondary progressive multiple sclerosis.

Ralf A Linker, Andrew Chan, Martin Sommer, Michael Koziolek, Gerhard-Anton Müller, Walter Paulus, Ralf Gold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17703342     DOI： 10.1007/s00415-006-0497-0

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  10 in total

Review 1.  Plasma exchange for severe optic neuritis: treatment of 10 patients.

Authors:  K Ruprecht; E Klinker; T Dintelmann; P Rieckmann; R Gold
Journal:  Neurology       Date:  2004-09-28       Impact factor: 9.910

2.  [Plasma exchange therapy for steroid-unresponsive multiple sclerosis relapses: clinical experience with 16 patients].

Authors:  S Schilling; R A Linker; F B König; M Koziolek; M Bähr; G A Müller; W Paulus; J Gärtner; W Brück; A Chan; R Gold
Journal:  Nervenarzt       Date:  2006-04       Impact factor: 1.214

3.  Plasma exchange combined with azathioprine in multiple sclerosis using serial gadolinium-enhanced MRI to monitor disease activity: a randomized single-masked cross-over pilot study.

Authors:  P S Sørensen; B Wanscher; W Szpirt; C V Jensen; M Ravnborg; P Christiansen; K Schreiber; A Nordenbo
Journal:  Neurology       Date:  1996-06       Impact factor: 9.910

4.  Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease.

Authors:  S J Pittock; R L McClelland; S J Achenbach; F Konig; A Bitsch; W Brück; H Lassmann; J E Parisi; B W Scheithauer; M Rodriguez; B G Weinshenker; C F Lucchinetti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

5.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

6.  Chronic progressive multiple sclerosis: double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs.

Authors:  B O Khatri; M P McQuillen; G J Harrington; D Schmoll; R G Hoffmann
Journal:  Neurology       Date:  1985-03       Impact factor: 9.910

7.  Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange.

Authors:  Mark Keegan; Fatima König; Robyn McClelland; Wolfgang Brück; Yazmín Morales; Andreas Bitsch; Hillel Panitch; Hans Lassmann; Brian Weinshenker; Moses Rodriguez; Joseph Parisi; Claudia F Lucchinetti
Journal:  Lancet       Date:  2005 Aug 13-19       Impact factor: 79.321

8.  A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

Authors:  B G Weinshenker; P C O'Brien; T M Petterson; J H Noseworthy; C F Lucchinetti; D W Dodick; A A Pineda; L N Stevens; M Rodriguez
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

9.  The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group.

Authors: 
Journal:  Lancet       Date:  1991-02-23       Impact factor: 79.321

10.  Plasma exchange for severe attacks of CNS demyelination: predictors of response.

Authors:  M Keegan; A A Pineda; R L McClelland; C H Darby; M Rodriguez; B G Weinshenker
Journal:  Neurology       Date:  2002-01-08       Impact factor: 9.910
  10 in total
  6 in total

Review 1.  Corticosteroids and plasma exchange in multiple sclerosis.

Authors:  Hayretin Tumani
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

2.  Management of acute exacerbations in multiple sclerosis.

Authors:  Daniel Ontaneda; Alex D Rae-Grant
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

3.  Combination therapy with mitoxantrone and plasma exchange in aggressive relapsing remitting multiple sclerosis: A preliminary clinical study.

Authors:  Nasim Tabrizi; Masoud Etemadifar; Fereshteh Ashtari; Arash Zahed; Fatemeh Etemadifar
Journal:  J Res Med Sci       Date:  2012-09       Impact factor: 1.852

Review 4.  Monomethyl Fumarate (MMF, Bafiertam) for the Treatment of Relapsing Forms of Multiple Sclerosis (MS).

Authors:  Amnon A Berger; Emily R Sottosanti; Ariel Winnick; Jonathan Izygon; Kevin Berardino; Elyse M Cornett; Alan D Kaye; Giustino Varrassi; Omar Viswanath; Ivan Urits
Journal:  Neurol Int       Date:  2021-05-19

5.  Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients.

Authors:  Johannes Ehler; Sebastian Koball; Martin Sauer; Steffen Mitzner; Heiko Hickstein; Reiner Benecke; Uwe K Zettl
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

6.  Aggressive multiple sclerosis (2): Treatment.

Authors:  Georgina Arrambide; Ellen Iacobaeus; Maria Pia Amato; Tobias Derfuss; Sandra Vukusic; Bernhard Hemmer; Lou Brundin; Mar Tintore
Journal:  Mult Scler       Date:  2020-06-12       Impact factor: 6.312
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.